BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Su A, Gandhy R, Barlow C, Triadafilopoulos G. A practical review of gastrointestinal manifestations in Parkinson's disease. Parkinsonism & Related Disorders 2017;39:17-26. [DOI: 10.1016/j.parkreldis.2017.02.029] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Rousseaux MWC, Shulman JM, Jankovic J. Progress toward an integrated understanding of Parkinson's disease. F1000Res 2017;6:1121. [PMID: 28751973 DOI: 10.12688/f1000research.11820.1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
2 Chung KA, Pfeiffer RF. Gastrointestinal dysfunction in the synucleinopathies. Clin Auton Res 2021;31:77-99. [PMID: 33247399 DOI: 10.1007/s10286-020-00745-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Travagli RA, Browning KN, Camilleri M. Parkinson disease and the gut: new insights into pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol 2020;17:673-85. [PMID: 32737460 DOI: 10.1038/s41575-020-0339-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 26.0] [Reference Citation Analysis]
4 Mozaffari S, Nikfar S, Daniali M, Abdollahi M. The pharmacological management of constipation in patients with Parkinson's disease: a much-needed relief. Expert Opin Pharmacother 2020;21:701-7. [PMID: 32037901 DOI: 10.1080/14656566.2020.1726319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wollmer E, Klein S. A review of patient-specific gastrointestinal parameters as a platform for developing in vitro models for predicting the in vivo performance of oral dosage forms in patients with Parkinson’s disease. International Journal of Pharmaceutics 2017;533:298-314. [DOI: 10.1016/j.ijpharm.2017.08.126] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
6 Chukwurah E, Osmundsen A, Davis SW, Lizarraga SB. All Together Now: Modeling the Interaction of Neural With Non-neural Systems Using Organoid Models. Front Neurosci 2019;13:582. [PMID: 31293366 DOI: 10.3389/fnins.2019.00582] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
7 Shen T, Yue Y, He T, Huang C, Qu B, Lv W, Lai HY. The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis. Front Aging Neurosci 2021;13:636545. [PMID: 33643026 DOI: 10.3389/fnagi.2021.636545] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Hwang H, Norris SA. Managing Advanced Parkinson Disease. J Geriatr Psychiatry Neurol 2021;34:289-300. [PMID: 34219527 DOI: 10.1177/08919887211018277] [Reference Citation Analysis]
9 Hurt CS, Rixon L, Chaudhuri KR, Moss-Morris R, Samuel M, Brown RG. Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson's. Parkinsonism Relat Disord 2019;64:220-5. [PMID: 31036430 DOI: 10.1016/j.parkreldis.2019.04.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
10 Stillhart C, Vučićević K, Augustijns P, Basit AW, Batchelor H, Flanagan TR, Gesquiere I, Greupink R, Keszthelyi D, Koskinen M, Madla CM, Matthys C, Miljuš G, Mooij MG, Parrott N, Ungell A, de Wildt SN, Orlu M, Klein S, Müllertz A. Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review. European Journal of Pharmaceutical Sciences 2020;147:105280. [DOI: 10.1016/j.ejps.2020.105280] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 37.0] [Reference Citation Analysis]
11 Sun BH, Wang T, Li NY, Wu Q, Qiao J. Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease. World J Gastrointest Pharmacol Ther 2021;12:21-31. [PMID: 33564494 DOI: 10.4292/wjgpt.v12.i1.21] [Reference Citation Analysis]
12 Morais LH, Hara DB, Bicca MA, Poli A, Takahashi RN. Early signs of colonic inflammation, intestinal dysfunction, and olfactory impairments in the rotenone-induced mouse model of Parkinson's disease. Behav Pharmacol 2018;29:199-210. [PMID: 29543651 DOI: 10.1097/FBP.0000000000000389] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
13 Shin CM, Lee YJ, Kim JM, Lee JY, Kim KJ, Choi YJ, Kim N, Lee DH. DA-9701 on gastric motility in patients with Parkinson's disease: A randomized controlled trial. Parkinsonism Relat Disord 2018;54:84-9. [PMID: 29705555 DOI: 10.1016/j.parkreldis.2018.04.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
14 Choi JH, Lee JY, Cho JW, Koh SB, Yang YS, Yoo D, Shin CM, Kim HT. Double-Blind, Randomized, Placebo-Controlled Trial of DA-9701 in Parkinson's Disease: PASS-GI Study. Mov Disord 2020;35:1966-76. [PMID: 32761955 DOI: 10.1002/mds.28219] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Wong J, Chopra J, Chiang LLW, Liu T, Ho J, Wu WKK, Tse G, Wong SH. The Role of Connexins in Gastrointestinal Diseases. J Mol Biol 2019;431:643-52. [PMID: 30639409 DOI: 10.1016/j.jmb.2019.01.007] [Reference Citation Analysis]
16 Tan EK, Chao YX, West A, Chan LL, Poewe W, Jankovic J. Parkinson disease and the immune system - associations, mechanisms and therapeutics. Nat Rev Neurol 2020;16:303-18. [PMID: 32332985 DOI: 10.1038/s41582-020-0344-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 57.0] [Reference Citation Analysis]
17 Triadafilopoulos G, Gandhy R, Barlow C. Pilot cohort study of endoscopic botulinum neurotoxin injection in Parkinson's disease. Parkinsonism Relat Disord 2017;44:33-7. [PMID: 28847681 DOI: 10.1016/j.parkreldis.2017.08.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
18 Palma JA, Kaufmann H. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord 2018;33:372-90. [PMID: 29508455 DOI: 10.1002/mds.27344] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 40.0] [Reference Citation Analysis]